Sokol, L. L., Ashner, M. C., Bega, D., Kluger, B. M., Smith, A. K., Marder, K. S., & Garcia, T. P. (2025). Spiritual Well-Being and Phenoconversion in Huntington’s Disease: Analysis from the Prospective Huntington at Risk Observational Study. Journal of Palliative Medicine, 000–000. https://doi.org/10.1089/jpm.2024.0227

Barca, E., Kroopnick, A., Houck, A., Thakur, K., Dugue, R., Zolkipli-Cunningham, Z., Falk, M., Goldstein, A., Demczko, M., Gavrilova, R., Larson, A., Van Hove, J., Saneto, R., Buchsbaum, R., Thompson, J., & Hirano, M. (2024). Adult-onset Leigh Syndrome: An analysis of the North American Mitochondrial Disease Consortium Database (P3-11.017). Neurology, 102(7_supplement_1). https://doi.org/10.1212/wnl.0000000000206383

Kost, R. G., Andrews, J., Chatterjee, R., Cheng, A. C., Connally, L., Dozier, A., Dykes, C., Ford, D., Green, N. S., Jiang, C., Khoury-Shakour, S., Lindo, S., Marder, K., Martinez, L., Qureshi, A., Roberts, J., & Schlesinger, N. (2025). What research participants say about their research experiences in Empowering the Participant Voice: Outcomes and actionable data. Journal of Clinical and Translational Science, 9(1). https://doi.org/10.1017/cts.2025.3

Siemers, E., Feaster, T., Sethuraman, G., Sundell, K., Skljarevski, V., Cline, E. N., Zhang, H., Jerecic, J., Honig, L. S., Salloway, S., Sperling, R., Trame, M. N., Dodds, M. G., & Johnson, K. (2025). INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer’s disease. The Journal of Prevention of Alzheimer’s Disease, 12(1), 100005. https://doi.org/10.1016/j.tjpad.2024.100005

Siemers, E. R., Evans, E. E., Fisher, T. L., Boise, M., Foster, A., Leonard, J. E., Mishra, V., Mallow, C. L., Porsteinsson, A. P., Turner, R. S., Bond, W., Huffaker, J., Farlow, M. R., Honig, L. S., Sheldon, E., Townley, R. A., Winner, P., Norton, J., Holub, R., … Zauderer, M. (2024). Results of SIGNAL‐AD, a randomized, phase 1b/2 trial to evaluate safety and efficacy of targeting reactive astrocytes with pepinemab, SEMA4D blocking antibody, in people with mild Alzheimer’s dementia. Alzheimer’s & Dementia, 20(S2). Portico. https://doi.org/10.1002/alz.092538

Joyce, J. L., Cosentino, S., Rizer, S., Dargie, S. A., Chapman, S., Mora, L., Libon, D. J., Tom, S. E., Marder, K., & Rosser, M. (2024). Preliminary Findings from EMPOWER: Evaluating Memory as Part of Women’s Routine Care. Alzheimer’s & Dementia, 20(S3). Portico. https://doi.org/10.1002/alz.092824

Mielke, M. M., Kurzman, H. R., Hu, Y. H., Cho, M., Liss, J., Burns, J. M., Obisesan, T. O., Hornbecker, M., Pallay, A., Smith, S. R., Honig, L. S., Parker, M. W., Bell, J., & Hampel, H. (2024). Advancing Early Detection of Alzheimer’s Disease in the Primary Care Setting in the United States. Alzheimer’s & Dementia, 20(S2). Portico. https://doi.org/10.1002/alz.086582

Biber, S. A., Prado, M. G., Culhane, J. E., Phuong, J., Keller, B., Lerch, M., Wang, S., Noble, J. M., Moulder, K. L., Saykin, A. J., Gao, S., Lai, A., Natarajan, K., Kukull, W. A., Mooney, S., & Stephens, K. (2024). Advancing Alzheimer’s disease and related dementias (ADRD) and COVID‐19 research by linking real‐world data with a standardized longitudinal ADRD data platform. Alzheimer’s & Dementia, 20(S8). Portico. https://doi.org/10.1002/alz.094785

McLachlan, M., Rouanet, J. P., Garimella, A., Price, J. C., Tudorascu, D., Laymon, C. M., Keator, D. B., Betthauser, T. J., Kreisl, W. C., Lao, P. J., Minhas, D. S., Klunk, W. E., Cohen, A., Handen, B. L., Fryer, T. D., Zaman, S., Koeppe, R. A., Head, E., Mapstone, M., … Christian, B. T. (2024). Comparison of reference region stability for longitudinal amyloid PET in Down syndrome. Alzheimer’s & Dementia, 20(S2). Portico. https://doi.org/10.1002/alz.092918

Caro, D. D., Rodriguez, S., Wetmore, J. B., Godinez, J. D., Camarillo, I. A., Goldman, J., Uhlmann, W. R., McCain, S., Caban, M., Leu, C., Abraido‐Lanza, A. F., Lantigua, R. A., Chung, W. K., Roberts, J. S., Siegel, K., & Ottman, R. (2024). Exploring the Immediate Impact of APOE ε4ε4 Genotype Disclosure among Latinos. Alzheimer’s & Dementia, 20(S1). Portico. https://doi.org/10.1002/alz.086185

McLachlan, M., Rouanet, J. P., Garimella, A., Price, J. C., Tudorascu, D., Laymon, C. M., Keator, D. B., Betthauser, T. J., Kreisl, W. C., Lao, P. J., Minhas, D. S., Klunk, W. E., Cohen, A., Handen, B. L., Fryer, T. D., Zaman, S., Koeppe, R. A., Head, E., Mapstone, M., … Christian, B. T. (2024). Comparison of reference region stability for longitudinal amyloid PET in Down syndrome. Alzheimer’s & Dementia, 20(S9). Portico. https://doi.org/10.1002/alz.094104

Houlihan, H. M., Johnson, A. S., Smith, A. C., Guzmán, D. S., Okafor, A., Heuer, L. B., Talmasov, D., Chikwem, N., Dass, D. S., Noble, J. M., Kreisl, W. C., Small, S. A., & Lao, P. J. (2024). Microglia density measured by TSPO PET across amyloid positivity and clinical variants. Alzheimer’s & Dementia, 20(S8). Portico. https://doi.org/10.1002/alz.095057

Rizer, S., Joyce, J. L., Dargie, S. A., Chapman, S., Libon, D. J., Mora, L., Tom, S. E., Marder, K., Rosser, M., & Cosentino, S. (2024). Digital Cognitive Screening Outcomes in Older Women at the Annual Well Woman Visit. Alzheimer’s & Dementia, 20(S3). Portico. https://doi.org/10.1002/alz.092636

Cornejo‐Olivas, M., Griswold, A. J., Saldarriaga‐Mayo, A., Mena, P. R., Rodriguez, R. S., Adams, L. D., Whitehead, P. L., Isasi, R., Illanes‐Manrique, M., Sarapura‐Castro, E., Rajabli, F., McInerney, K. F., Milla‐Neyra, K., Manrique‐Enciso, C., Beecham, G. W., Castro‐Suarez, S., George‐Hyslop, P. S., Araujo‐Aliaga, I., Cuccaro, M. L., … Pericak‐Vance, M. A. (2024). A novel stop‐gain SORL1 mutation from Amerindian background in a Peruvian family with Alzheimer’s Disease of the PeADI Study. Alzheimer’s & Dementia, 20(S1). Portico. https://doi.org/10.1002/alz.090818

Honig, L. S., Kim, J. M., Gonzalez, W. P., DiMuro, V., Jagannathan, R., Marder, K., Noble, J. M., Bell, K. L., & Mayeux, R. (2024). Clinical Use of Lecanemab at an Academic Medical Center. Alzheimer’s & Dementia, 20(S8). Portico. https://doi.org/10.1002/alz.095181

Idnay, B., Zhang, G., Chen, F., Ta, C. N., Schelke, M. W., Marder, K., & Weng, C. (2024). Mini-mental status examination phenotyping for Alzheimer’s disease patients using both structured and narrative electronic health record features. Journal of the American Medical Informatics Association. https://doi.org/10.1093/jamia/ocae274

Oas, H., Cook, L., Schwantes-An, T.-H., Walsh, L. E., Wills, A.-M., Mata, I. F., Nance, M. A., Beck, J. C., Naito, A., Marder, K., Alcalay, R. N., & Verbrugge, J. (2024). Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participation. Npj Parkinson’s Disease, 10(1). https://doi.org/10.1038/s41531-024-00805-z

Idnay, B., Gordon, E. R., Johnson, A. S., Nestor, J. G., Marder, K., & Weng, C. (2024). Clinical researchers’ insights on key data for eligibility screening in clinical studies. Journal of Clinical and Translational Science, 8(1). https://doi.org/10.1017/cts.2024.617

Wetmore, J. B., Rodriguez, S., Diaz Caro, D., Cabán, M., Uhlmann, W., Goldman, J., Leu, C., Godinez, J. D., Camarillo, I. A., Ferber, R., Blasco, D., Lantigua, R. A., Abraído‐Lanza, A., Chung, W. K., Roberts, J. S., Siegel, K., & Ottman, R. (2024). Designing and implementing the IDEAL Study: A randomized clinical trial of APOE genotype disclosure for late‐onset Alzheimer’s disease in an urban Latino population. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 10(4). Portico. https://doi.org/10.1002/trc2.70016

McDonnell, E. I., Xie, S., Marder, K., Cui, F., & Wang, Y. (2024). Dynamic undirected graphical models for time‐varying clinical symptom and neuroimaging networks. Statistics in Medicine, 43(21), 4131–4147. Portico. https://doi.org/10.1002/sim.10143

Coughlin, D. G., MacLeod, K. R., Middleton, J. S., Bozoki, A. C., Galvin, J. E., Irwin, D. J., Lippa, C. F., Litvan, I., Lopez, O. L., Berman, S., Tsuang, D. W., Zabetian, C. P., Honig, L. S., Marder, K. S., Fleisher, J. E., Sabbagh, M., Wint, D., Taylor, A. S., Bekris, L., … Galasko, D. (2024). Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy Bodies. Neurology, 103(3). https://doi.org/10.1212/wnl.0000000000209656

Idnay, B., Fang, Y., Stanley, E., Ruotolo, B., Chung, W. K., Marder, K., & Weng, C. (2024). Promoting equity in clinical research: The role of social determinants of health. Journal of Biomedical Informatics, 156, 104663. https://doi.org/10.1016/j.jbi.2024.104663

Cook, L., Verbrugge, J., Schwantes-An, T.-H., Schulze, J., Foroud, T., Hall, A., Marder, K. S., Mata, I. F., Mencacci, N. E., Nance, M. A., Schwarzschild, M. A., Simuni, T., Bressman, S., Wills, A.-M., Fernandez, H. H., Litvan, I., Lyons, K. E., Shill, H. A., Singer, C., … Alcalay, R. N. (2024). Parkinson’s disease variant detection and disclosure: PD GENEration, a North American study. Brain, 147(8), 2668–2679. https://doi.org/10.1093/brain/awae142

Joyce, J. L., Chapman, S., Waltrip, L., Caes, D., Gottesman, R., Rizer, S., Haque, H., Golfer, L., Mayeux, R. P., D’Alton, M. E., Marder, K., Rosser, M., & Cosentino, S. (2024). Confronting Alzheimer’s Disease Risk in Women: A Feasibility Study of Memory Screening as Part of the Annual Gynecological Well-Woman Visit. Journal of Women’s Health. https://doi.org/10.1089/jwh.2023.0843

van Tartwijk, F. W., Wunderlich, L. C. S., Mela, I., Makarchuk, S., Jakobs, M. A. H., Qamar, S., Franze, K., Kaminski Schierle, G. S., St George-Hyslop, P. H., Lin, J. Q., Holt, C. E., & Kaminski, C. F. (2024). Mutation of the ALS-/FTD-Associated RNA-Binding Protein FUS Affects Axonal Development. The Journal of Neuroscience, 44(27), e2148232024. https://doi.org/10.1523/jneurosci.2148-23.2024

Dratch, L., Kinnamon, D. D., Harrington, E. A., Goldman, J., Fong, J. C., Jones, T., Uhlmann, W. R., & Roggenbuck, J. (2024). Response to “assessment of risk of ALS conferred by the GGGGCC hexanucleotide expansion in C9orf72 among first-degree relatives of patients with ALS carrying the repeat expansion.” Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1–3. https://doi.org/10.1080/21678421.2024.2362854

Kalaria, R., Maestre, G., Mahinrad, S., Acosta, D. M., Akinyemi, R. O., Alladi, S., Allegri, R. F., Arshad, F., Babalola, D. O., Baiyewu, O., Bak, T. H., Bellaj, T., Brodie‐Mends, D. K., Carrillo, M. C., Celestin, K., Damasceno, A., de Silva, R. K., de Silva, R., Djibuti, M., … Ismail, O. (2024). The 2022 symposium on dementia and brain aging in low‐ and middle‐income countries: Highlights on research, diagnosis, care, and impact. Alzheimer’s & Dementia, 20(6), 4290–4314. Portico. https://doi.org/10.1002/alz.13836

Idnay, B., Liu, J., Fang, Y., Hernandez, A., Kaw, S., Etwaru, A., Juarez Padilla, J., Ramírez, S. O., Marder, K., Weng, C., & Schnall, R. (2024). Sociotechnical feasibility of natural language processing-driven tools in clinical trial eligibility prescreening for Alzheimer’s disease and related dementias. Journal of the American Medical Informatics Association, 31(5), 1062–1073. https://doi.org/10.1093/jamia/ocae032

Ryvicker, M., Barrón, Y., Song, J., Zolnoori, M., Shah, S., Burgdorf, J. G., Noble, J. M., & Topaz, M. (2024). Using Natural Language Processing to Identify Home Health Care Patients at Risk for Diagnosis of Alzheimer’s Disease and Related Dementias. Journal of Applied Gerontology. https://doi.org/10.1177/07334648241242321

Anastasi, J. K., Capili, B., Norton, M., McMahon, D. J., & Marder, K. (2024). Recruitment and retention of clinical trial participants: understanding motivations of patients with chronic pain and other populations. Frontiers in Pain Research, 4. https://doi.org/10.3389/fpain.2023.1330937

Arias, J. J., Tyler, A. M., Beskow, L. M., Carillo, M. C., Dickinson, S., Goldman, J., Majumder, M. A., Mello, M. M., Snyder, H. M., & Yokoyama, J. S. (2024). Data stewardship in FTLD research: Investigator and research participant views. Alzheimer’s & Dementia, 20(4), 2886–2893. Portico. https://doi.org/10.1002/alz.13719

Ma, D. J., Yang, Y., Harguindeguy, N., Tian, Y., Small, S. A., Liu, F., Rothman, D. L., & Guo, J. (2023). Magnetic Resonance Spectroscopy Spectral Registration Using Deep Learning. Journal of Magnetic Resonance Imaging, 59(3), 964–975. Portico. https://doi.org/10.1002/jmri.28868

Wang, G., Li, Y., Xiong, C., Benzinger, T. L. S., Gordon, B. A., Hassenstab, J., Aschenbrenner, A. J., McDade, E., Clifford, D. B., Libre‐Guerra, J. J., Shi, X., Mummery, C. J., van Dyck, C. H., Lah, J. J., Honig, L. S., Day, G., Ringman, J. M., Brooks, W. S., … Fox, N. C. (2024). Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer’s disease. Alzheimer’s & Dementia, 20(4), 2698–2706. Portico. https://doi.org/10.1002/alz.13735

Cullen, P. J., Holstege, H., Small, S. A., & St George-Hyslop, P. (2024). Understanding the endo-lysosomal network in neurodegeneration. Philosophical Transactions of the Royal Society B: Biological Sciences, 379(1899). https://doi.org/10.1098/rstb.2022.0372

Alessi, D. R., Cullen, P. J., Cookson, M., Merchant, K. M., & Small, S. A. (2024). Retromer-dependent lysosomal stress in Parkinson’s disease. Philosophical Transactions of the Royal Society B: Biological Sciences, 379(1899). https://doi.org/10.1098/rstb.2022.0376

Middleton, J., MacLeod, K. R., Bozoki, A., Galvin, J. E., Irwin, D. J., Lippa, C., Litvan, I., Lopez, O. L., Berman, S., Tsuang, D. W., Zabetian, C. P., Honig, L. S., Marder, K., Fleisher, J. E., Sabbagh, M., Wint, D., Taylor, A., Bekris, L. M., Leverenz, J. B., & Galasko, D. R. (2023). Use of α‐synuclein seed amplification assays to assess how clinical features relate to the diagnosis of Dementia with Lewy Bodies. Alzheimer’s & Dementia, 19(S14). Portico. https://doi.org/10.1002/alz.078103

Joyce, J., Chapman, S., Gifford, K. A., Shagalow, S., Waltrip, L. H., Zeiger, P., Kann, M., Ravichander, A., Rizer, S., Marder, K., Jefferson, A. L., & Cosentino, S. (2023). Sex/gender differences in subjective cognitive decline’s association to cognition and depression. Alzheimer’s & Dementia, 19(S22). Portico. https://doi.org/10.1002/alz.073811

Sudhakar, T. D., Levendovszky, S. R., Zabetian, C. P., Tsuang, D. W., Pillai, J. A., Rao, S. M., Oguh, O., Lippa, C., Lopez, O. L., Berman, S., Irwin, D. J., Galasko, D. R., Litvan, I., Marder, K., Honig, L. S., Fleisher, J. E., Galvin, J. E., Bozoki, A., Taylor, A., … Olson, V. (2023). Identification of Hippocampal and Amygdala Subfields Predictive of MoCA Scores in Patients with Dementia with Lewy Bodies. Alzheimer’s & Dementia, 19(S24). Portico. https://doi.org/10.1002/alz.082764

Jain, L., Khrestian, M., Formica, S., Tuason, E. D., Pillai, J. A., Rao, S. M., Oguh, O., Lippa, C., Lopez, O. L., Berman, S., Tsuang, D. W., Zabetian, C. P., Irwin, D. J., Galasko, D. R., Litvan, I., Marder, K., Honig, L. S., Fleisher, J. E., Galvin, J. E., … Bekris, L. M. (2023). ATN Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies: Initial Results from the United States Dementia with Lewy Bodies Consortium. Alzheimer’s & Dementia, 19(S21). Portico. https://doi.org/10.1002/alz.077443

Kim, H. J., Lane, K. A., Gao, S., Hammers, D. B., Logan, P. E., Aisen, P. S. S., Dage, J. L., Eloyan, A., Foroud, T. M., Grinberg, L. T., Iaccarino, L., Jack, C. R., Kramer, J. H., Koeppe, R. A., Kukull, W. A., La Joie, R., Mundada, N. S., Murray, M. E., Nudelman, K. N. H., … Apostolova, L. G. (2023). Cognitive Clusters of Early‐onset non‐Alzheimer’s disease. Alzheimer’s & Dementia, 19(S24). Portico. https://doi.org/10.1002/alz.083061

Zhang, J., Rao, V. M., Tian, Y., Yang, Y., Acosta, N., Wan, Z., Lee, P.-Y., Zhang, C., Kegeles, L. S., Small, S. A., & Guo, J. (2023). Detecting schizophrenia with 3D structural brain MRI using deep learning. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-41359-z

Goldman, J. S., Uhlmann, W. R., Naini, A. B., Klitzman, R. L., & Marder, K. S. (2023). Genetic Testing of HTT Modifiers for Huntington’s Disease: Considerations for Clinical Guidelines. Movement Disorders, 38(12), 2151–2154. Portico. https://doi.org/10.1002/mds.29650

Wiseman, L., Isbel, S., Boag, A., Halpin-Healy, C., Gibson, D., Bail, K., Noble, J. M., & D’Cunha, N. M. (2023). Online gallery facilitated art activities for people with dementia during the COVID-19 pandemic and beyond: A narrative review. Dementia, 22(8), 1950–1976. https://doi.org/10.1177/14713012231198748

Cook, L., Verbrugge, J., Schwantes-An, T.-H., Schulze, J., Beck, J. C., Naito, A., Hall, A., Chan, A. K., Casaceli, C. J., Marder, K., Nance, M., Schwarzschild, M. A., Simuni, T., Wills, A.-M., & Alcalay, R. N. (2023). Providing genetic testing and genetic counseling for Parkinson’s disease to the community. Genetics in Medicine, 25(10), 100907. https://doi.org/10.1016/j.gim.2023.100907

Jain, L., Khrestian, M., Formica, S., Tuason, E. D., Pillai, J. A., Rao, S., Oguh, O., Lippa, C. F., Lopez, O. L., Berman, S. B., Tsuang, D. W., Zabetian, C. P., Irwin, D. J., Galasko, D. R., Litvan, I., Marder, K. S., Honig, L. S., Fleisher, J. E., Galvin, J. E., … Bekris, L. M. (2023). ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium. Alzheimer’s & Dementia, 20(1), 549–562. Portico. https://doi.org/10.1002/alz.13398

Idnay, B., Fang, Y., Butler, A., Moran, J., Li, Z., Lee, J., Ta, C., Liu, C., Yuan, C., Chen, H., Stanley, E., Hripcsak, G., Larson, E., Marder, K., Chung, W., Ruotolo, B., & Weng, C. (2023). Uncovering key clinical trial features influencing recruitment. Journal of Clinical and Translational Science, 7(1). https://doi.org/10.1017/cts.2023.623

Zolnoori, M., Barrón, Y., Song, J., Noble, J., Burgdorf, J., Ryvicker, M., & Topaz, M. (2023). HomeADScreen: Developing Alzheimer’s disease and related dementia risk identification model in home healthcare. International Journal of Medical Informatics, 177, 105146. https://doi.org/10.1016/j.ijmedinf.2023.105146

Agin‐Liebes, J., Hickman, R. A., Vonsattel, J. P., Faust, P. L., Flowers, X., Utkina Sosunova, I., Ntiri, J., Mayeux, R., Surface, M., Marder, K., Fahn, S., Przedborski, S., & Alcalay, R. N. (2023). Patterns of TDP‐43 Deposition in Brains with LRRK2 G2019S Mutations. Movement Disorders, 38(8), 1541–1545. Portico. https://doi.org/10.1002/mds.29449

Pal, G., Cook, L., Schulze, J., Verbrugge, J., Alcalay, R. N., Merello, M., Sue, C. M., Bardien, S., Bonifati, V., Chung, S. J., Foroud, T., Gatto, E., Hall, A., Hattori, N., Lynch, T., Marder, K., Mascalzoni, D., Novaković, I., Thaler, A., … Klein, C. (2023). Genetic Testing in Parkinson’s Disease. Movement Disorders, 38(8), 1384–1396. Portico. https://doi.org/10.1002/mds.29500

Saunders‐Pullman, R., Raymond, D., Ortega, R. A., Shalash, A., Gatto, E., Salari, M., Markgraf, M., Alcalay, R. N., Mascalzoni, D., Mencacci, N. E., Bonifati, V., Merello, M., Chung, S. J., Novakovic, I., Bardien, S., Pal, G., Hall, A., Hattori, N., Lynch, T., … Simuni, T. (2023). International Genetic Testing and Counseling Practices for Parkinson’s Disease. Movement Disorders, 38(8), 1527–1535. Portico. https://doi.org/10.1002/mds.29442